Document is current
Any future updates will be listed below
-
Authors
Swiatkiewicz, Iwona http://orcid.org/0000-0002-6983-7170
Patel, Neeja T.
Villarreal-Gonzalez, MaryAnn
Taub, Pam R.
-
Funding
Funding for this research was provided by:
Applied Therapeutics (investigator-initiated research grant)
- License Information
-
More Information
Article History
Received: 16 November 2023
Accepted: 22 April 2024
First Online: 14 May 2024
Declarations
:
: The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the University California San Diego, La Jolla, USA (IRB 200205/2020). Written informed consent for the participation in the study was waived given retrospective nature of this analysis.
: Not applicable.
: P.R.T. declared Consultant to Sanofi, Novo-Nordisk, Boehringer-Ingelheim, Medtronic, Novartis, Amgen, and Esperion. Founder and Shareholder of Epirium Bio. Grants: NIH R01 DK118278; investigator-initiated grant from Applied Therapeutics. Other authors declare no conflict of interest.
